Nemaura Medical Inc. (NMRD)

Market Cap	40.00 -100.0%
Revenue (ttm)	n/a -84.7%
Net Income	-10.65M
EPS	-0.38
Shares Out	40.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	6,992
Open	0.0002
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	-117.28
RSI	48.06
Earnings Date	Feb 11, 2026

About Nemaura Medical

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 36
• Stock Exchange: OTCMKTS
• Ticker Symbol: NMRD

Financial Performance

In fiscal year 2023, Nemaura Medical's revenue was $77,044, a decrease of -84.71% compared to the previous year's $503,906. Losses were -$14.14 million, 1.85% more than in 2022.